Growth Metrics

Enanta Pharmaceuticals (ENTA) Enterprise Value (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.88%
Dec 31, 2025 1.60%
Sep 30, 2025 7.47%
Jun 30, 2025 -5.55%
Mar 31, 2025 10.76%
Dec 31, 2024 12.69%
Sep 30, 2024 -7.87%
Jun 30, 2024 23.38%
Mar 31, 2024 10.93%
Dec 31, 2023 -294.85%
Sep 30, 2023 77.91%
Jun 30, 2023 -84.01%
Mar 31, 2023 2.05%
Dec 31, 2022 13.95%
Sep 30, 2022 1.60%
Jun 30, 2022 9.65%
Mar 31, 2022 -8.21%
Dec 31, 2021 -6.17%
Sep 30, 2021 4.99%
Jun 30, 2021 31.69%
Mar 31, 2021 2.65%
Dec 31, 2020 0.12%
Sep 30, 2020 -4.50%
Jun 30, 2020 -4.15%
Mar 31, 2020 4.96%
Dec 31, 2019 -11.50%
Sep 30, 2019 13.88%
Jun 30, 2019 -5.16%
Mar 31, 2019 -7.05%
Dec 31, 2018 -12.00%
Sep 30, 2018 -12.99%
Jun 30, 2018 -6.43%
Mar 31, 2018 -16.46%
Dec 31, 2017 1.44%
Sep 30, 2017 -16.49%
Jun 30, 2017 -9.36%
Mar 31, 2017 16.14%
Dec 31, 2016 0.35%
Sep 30, 2016 3.84%
Jun 30, 2016 0.89%
Mar 31, 2016 -22.56%
Dec 31, 2015 -24.00%
Sep 30, 2015 5.88%
Jun 30, 2015 6.87%
Mar 31, 2015 -59.07%
Dec 31, 2014 -14.86%
Sep 30, 2014 5.55%
Jun 30, 2014 -1.18%
Mar 31, 2014 -3.13%
Dec 31, 2013 9.45%
Sep 30, 2013 -7.33%
Jun 30, 2013 13.35%
Mar 31, 2013 -426.22%
Dec 31, 2012 52.62%
Sep 30, 2012 -1,004.82%
Jun 30, 2012 80.87%